The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price increase of 210.48%. However, over the past six months, we’ve seen a
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Year to date metric has recorded a gain of 245.71%.However, over the last six months, we can see a
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The metric has seen a significant gain of 261.90% since the start of this calendar year. Looking back
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. This year’s metric has recorded a Price increase of 199.05%. However, over the past six months, we’ve seen a weaker performance of 163.87%. The
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Until today this year the stock’s price performance recorded an increase of 107.62%. However, over
A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Aclaris Therapeutics Inc’s current trading price is -63.37% away from its 52-week high, while its distance from the 52-week low is 254.12%. The stock’s
The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Aclaris Therapeutics Inc’s current trading price is -71.78% away from its 52-week high, while its distance from the 52-week low is 172.79%. The stock’s price
The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Aclaris Therapeutics Inc’s current trading price is -74.86% away from its 52-week high, while its distance from the 52-week low is 143.02%. The stock’s price
All rights reserved © 2024, Powered By Smart TechOne
